| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.035 | 0.5 |